Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Encharge
- Development stage
- Unknown
- Lead developer
- TCF Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Encharge (also marketed as Encharge-40) is a nutritional supplement developed by TCF Pharmaceuticals. It is formulated as an oral capsule containing a blend of 40 multivitamin and mineral ingredients. Encharge is indicated for the prevention and treatment of nutritional deficiencies, helping to support overall health and metabolic function by replenishing essential micronutrients.
- Brand names
- EnchargeEncharge-40Encharge40Encharge 40
- Other names
- Multivitamin 40 Ingredients CapsulesMultivitamin40 Ingredients CapsulesMultivitamin-40 Ingredients CapsulesMultivitamin supplement
Beyond the preview
Go deeper on Encharge.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Encharge.